Iscan Coreo
Payments companies reported to CMS as associated with Iscan Coreo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Iscan Coreo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Iscan Coreo
These are the largest totals companies reported as associated with Iscan Coreo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ali Gabali | Detroit, MI | Anatomic Pathology & Clinical Pathology | $1,150.25 |
| Sara Acree | Marietta, GA | Anatomic Pathology & Clinical Pathology | $772.90 |
| Weihua Tang | Hiram, GA | Anatomic Pathology & Clinical Pathology | $772.86 |
| Mohammed Ali | Chevy Chase, MD | Gastroenterology (Internal Medicine) | $688.68 |
| Roderick Kreisberg | Silver Spring, MD | Gastroenterology (Internal Medicine) | $648.68 |
| Meiklejohn Mckenzie | Cookeville, TN | Anatomic Pathology & Clinical Pathology | $619.91 |
| Daniel Neumann | Suffolk, VA | Gastroenterology (Internal Medicine) | $503.92 |
| William Morice | Rochester, MN | Anatomic Pathology & Clinical Pathology | $501.47 |
| Michael Icardi | Iowa City, IA | Anatomic Pathology & Clinical Pathology | $470.61 |
| Alan Wells | Pittsburgh, PA | $192.44 |
Prescribed Iscan Coreo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.